Top Page
Sinofert Holdings
(0297)
Sinofert Holdings (0297) vs. iShares MSCI Hong Kong ETF (EWH)
Sinofert Holdings Business Overview & Revenue Model
Sinofert Holdings Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.30B | 21.26B | 21.73B | 23.00B | 22.64B | 21.38B |
| Gross Profit | 2.86B | 2.50B | 2.26B | 2.29B | 1.91B | 1.97B |
| EBITDA | 1.59B | 1.28B | 1.35B | 1.22B | 880.53M | 777.63M |
| Net Income | 1.11B | 1.06B | 625.55M | 1.12B | 866.61M | 644.07M |
Balance Sheet | ||||||
| Total Assets | 19.93B | 21.42B | 21.98B | 20.82B | 17.49B | 17.11B |
| Cash, Cash Equivalents and Short-Term Investments | 4.08B | 3.81B | 3.92B | 3.36B | 1.32B | 767.21M |
| Total Debt | 1.79B | 1.87B | 1.83B | 1.82B | 1.09B | 1.77B |
| Total Liabilities | 8.63B | 10.78B | 12.06B | 11.09B | 8.51B | 8.94B |
| Stockholders Equity | 11.08B | 10.42B | 9.71B | 9.50B | 8.74B | 8.00B |
Cash Flow | ||||||
| Free Cash Flow | -404.19M | 784.62M | 1.85B | 812.75M | 220.34M | 389.36M |
| Operating Cash Flow | -131.45M | 1.04B | 2.49B | 2.00B | 1.57B | 990.37M |
| Investing Cash Flow | -82.22M | -1.50B | -1.46B | -152.99M | -103.93M | -676.72M |
| Financing Cash Flow | -393.26M | -356.46M | -478.02M | 185.09M | -911.40M | -879.07M |
Sinofert Holdings Technical Analysis
Sinofert Holdings Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$12.90B | 8.25 | 15.41% | 3.23% | 0.82% | 2.99% | |
71 Outperform | HK$10.68B | 8.91 | 10.34% | 3.66% | -0.34% | 64.10% | |
69 Neutral | HK$11.89B | 10.76 | 5.60% | 5.44% | -8.24% | -24.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$1.32B | 20.44 | 2.46% | 3.52% | -5.29% | -32.47% | |
59 Neutral | HK$1.18B | 16.45 | 3.61% | 2.20% | -8.51% | -68.34% | |
37 Underperform | HK$672.18M | -17.94 | -44.61% | ― | -5.79% | -129.73% |
Sinofert Holdings Corporate Events
Sinofert Holdings has renewed an intragroup services arrangement under which Sinochem UK will continue to provide local supplier relations and logistics support in Europe to Sinochem Macao from 1 January 2026 to 31 December 2028. The services will be charged at cost, with fees ranging from US$0.8 to US$8.5 per tonne and an annual cap of US$2.3 million, and will be invoiced quarterly with 10-day settlement terms. As Sinochem UK is a connected person via the group’s ultimate parent Sinochem Holdings, the deal is classified as a continuing connected transaction under Hong Kong Listing Rules, triggering reporting, announcement and annual review requirements but exempting it from independent shareholders’ approval, thereby formalising ongoing intra-group collaboration while maintaining regulatory compliance.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings has announced that its direct controlling shareholding, amounting to approximately 52.65% of its issued share capital, has been transferred from Syngenta HK to Sinochem HK for nominal consideration. Despite the change in the immediate controlling shareholder, both Syngenta HK and Sinochem HK are wholly owned by Sinochem Holdings, meaning the company’s ultimate control, strategic direction and overall governance remain unchanged for investors and other stakeholders.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings announced that its independent shareholders have approved, by poll at a special general meeting on 19 December 2025, the Financial Services Framework Agreement and the related maximum daily outstanding balance for deposit services. Due to Sinochem Holdings and its associates abstaining from voting in line with prior disclosure, only independent shareholders were eligible to vote, with 69.51% of the votes cast in favour and 30.49% against, underscoring sufficient but not unanimous support for the continued use of affiliated financial services, which will shape the company’s treasury management and related-party transaction framework going forward.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited announced that its subsidiary, Sinochem Fertilizer, has entered into a new IT Business Services Framework Agreement with Sinochem Digital Intelligence. This agreement, effective from January 1, 2026, to December 31, 2026, will ensure the continuation of IT services such as system operation, maintenance, and software procurement. This move highlights Sinofert’s commitment to enhancing its IT infrastructure, which is crucial for maintaining operational efficiency and competitiveness in the market. The transactions under this agreement are classified as continuing connected transactions, subject to certain regulatory requirements but exempt from independent shareholder approval.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited has announced a change in its controlling shareholder due to an intra-group restructuring. Syngenta Group (HK) Holdings Company Limited has agreed to transfer its 52.65% stake in Sinofert to Sinochem Hong Kong (Group) Company Limited. This transfer will make Sinochem HK the direct controlling shareholder while Sinochem Holdings remains the ultimate controlling shareholder. A waiver was granted to Sinochem HK from the obligation to make a mandatory general offer under the Takeovers Code, minimizing potential disruptions to stakeholders.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited has announced a special general meeting to be held on December 19, 2025, in Hong Kong. The meeting will address the approval of the Financial Services Framework Agreement and related Deposit Services, which are expected to impact the company’s financial operations. The resolution, if passed, will authorize the directors to execute necessary documents and actions for the implementation of these services, potentially affecting stakeholders by enhancing the company’s financial service capabilities.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited has announced the closure of its register of members from December 16 to December 19, 2025, to determine the entitlement of shareholders to attend and vote at the Special General Meeting (SGM) scheduled for December 19, 2025. This move is part of the company’s ongoing major and connected transactions under the Financial Services Framework Agreement, which may have implications for its operational and strategic directions.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited announced the resignation of Ms. Cheung Kar Mun, Cindy as the company secretary and a member of the corporate governance committee, effective November 24, 2025. Ms. Lai Ying Tung has been appointed as the new company secretary, bringing nearly a decade of experience in corporate secretarial services. The board expressed gratitude to Ms. Cheung for her contributions and welcomed Ms. Lai to her new role.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited announced a connected transaction involving its subsidiary, Sinochem Yunlong, which has entered into an EPC General Contracting Agreement with CBLE and Yunnan Qiangshi for the renewal and renovation of electrical and instrumentation equipment. This project, valued at up to RMB31,000,000, aims to enhance the safety and reliability of operations by upgrading outdated equipment. The transaction, classified as a connected transaction under the Listing Rules, does not require independent shareholders’ approval but must comply with reporting and announcement requirements.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited, through its subsidiary Sinochem Fuling, has announced a connected transaction involving the harmless phosphogypsum backfill utilization project. This initiative aligns with national policies requiring 100% harmless treatment of phosphogypsum by 2026. The project, valued at RMB62,644,158.09, involves CBLE and Zhejiang Tuohai as contractors for design, procurement, and construction. This transaction, under the General Contracting Agreement, is subject to reporting and announcement requirements but is exempt from independent shareholders’ approval, reflecting its strategic importance in enhancing land utilization efficiency and compliance with regulatory standards.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited announced its unaudited key operating data for the nine months ended 30 September 2025, reporting a turnover of approximately RMB19,373 million and a net profit of RMB1,364 million, marking a 6% increase from the previous year. Despite challenges such as high raw material costs and declining ammonia prices, the company advanced its ‘Bio+’ strategy, achieving synergies across its operations and driving steady development in its results.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited has entered into a new Financial Services Framework Agreement with Sinochem Finance, effective after approval by independent shareholders, to increase the maximum daily outstanding balance of deposits and extend the agreement’s term by three years. This move is part of the company’s strategy to optimize its financial operations and comply with the Hong Kong Listing Rules, which require reporting, announcement, and shareholder approval for major transactions. The agreement aims to enhance Sinofert’s financial flexibility and strengthen its market position, with implications for stakeholders including the need for independent shareholder approval and advisory from Somerley Capital Limited.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited has announced a revision of the annual cap for its continuing connected transactions under the Information System Services Agreement with Sinochem Information. The company anticipates that the fees payable under this agreement for 2025 will exceed the original cap, prompting the board to revise it. This adjustment reflects the company’s ongoing commitment to maintaining robust information system services, which include system operation, maintenance, software licensing, procurement, and artificial intelligence services. The revision is subject to certain reporting and review requirements but does not require independent shareholders’ approval.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.